Cindy Berejikian
Directeur des opérations chez MINERALYS THERAPEUTICS, INC.
Postes actifs de Cindy Berejikian
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Directeur des opérations | - | - |
Historique de carrière de Cindy Berejikian
Anciens postes connus de Cindy Berejikian
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AMGEN INC. | Directeur/Membre du Conseil | - | - |
| Corporate Officer/Principal | - | - | |
| OTONOMY | Corporate Officer/Principal | 04/02/2011 | - |
Formation de Cindy Berejikian
| University of California, Los Angeles | Masters Business Admin |
| University of California, Santa Barbara | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Cindy Berejikian
- Expérience
